Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus
Clinical trial NCT03312335 · COMPLETED
Trial details
- NCT number
- NCT03312335
- Sponsor
- Onur Boyman, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-08
- Primary completion
- 2019-12-23
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.